Hanneke Schuitemaker

机构：Johnson & Johnson (Israel), Johnson & Johnson (Netherlands) · ORCID：0000-0001-8563-2266

发表论文 439 篇 · 总被引 30848 次 · h-index 88

代表论文

• Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial (2024 · The Lancet Infectious Diseases · 被引 44)
• Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial (2024 · Nature Communications · 被引 23)
• Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques (2023 · Nature Communications · 被引 19)
• Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study (2024 · EBioMedicine · 被引 18)
• Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans (2023 · Frontiers in Immunology · 被引 18)
• Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models (2023 · npj Vaccines · 被引 18)